Originally published December 3 2005
UK approves use of cannabis-based drug for MS patients
by Mike Adams, the Health Ranger, NaturalNews Editor
UK drug minister Paul Goggins has approved the use of Sativex, a cannabis-based treatment, for patients suffering from multiple sclerosis.
A small number of patients will be allowed an unlicensed cannabis-based treatment for multiple sclerosis.
Paul Goggins, the drugs minister, has approved the use of Sativex following requests from individual patients and doctors.
The treatment, in which the principle active components are cannabinoids, medically therapeutic products of cannabis, is administered as a spray under the tongue or on the inside of the cheek.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml